Phenytoin-mediated oxidative stress in serum of female epileptics: A possible pathogenesis in the fetal hydantoin syndrome

Human & Experimental Toxicology

Volumn 16, Issue 3, 1997, Pages 177-181

  Liu, Chin San ^a,b,c   Wu, Hong Ming ^c   Kao, Shu Huei ^a   Wei, Yau Huei ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^c Taichung Munic Aging Care Hospital   (Taiwan)

Author keywords

glutathione; lipid peroxidation; phenytoin; superoxide dismutase

Indexed keywords

COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; MALONALDEHYDE; PHENYTOIN; ZINC;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; COPPER BLOOD LEVEL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EPILEPSY; FEMALE; FETAL HYDANTOIN SYNDROME; HUMAN; LIPID PEROXIDATION; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ZINC BLOOD LEVEL;

ANALYSIS OF VARIANCE; ANTICONVULSANTS; COPPER; EPILEPSY; FEMALE; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATIVE STRESS; PHENYTOIN; PREGNANCY; PREGNANCY COMPLICATIONS; SPECTROPHOTOMETRY, ATOMIC; SUPEROXIDE DISMUTASE; ZINC;

EID: 0030960499     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719701600308     Document Type: Article

References (28)

1. Aust SD et al. Free radicals in toxicology. Toxicology and Applied Pharmacology 1993; 120: 168-78.
2. Roy D., Snodgrass WR Covalent binding of phenytoin to protein and modulation of diphenylhydantoin metabolism by thiols in A/J mouse liver microsomes. Journal of Pharmacology and Experimental Therapeutics 1990; 252: 895-900.
3. Eling TE et al. Prostaglandin H synthetase and xenobiotic oxidation. Annual Reviews of Pharmacology and Toxicology 1990; 30: 1-45.
4. Plum CM, Hansen SE Studies on variation in serum copper and copper oxidase activity, together with studies on the copper content of the cerebrospinal fluid, with particular reference to the variations in multiple sclerosis. Acta Psychiatrica Scandinavica 1960; 148: 41 - 78.
5. Cantu RC, Schwab RS Ceruloplasmin rise and PBI fall in serum due to diphenylhydantoin. Archives of Neurology 1996; 15: 393 - 6.
6. Taylor JD, Krahn PM, Higgins TN Serum copper levels and diphenylhydantoin. American Journal of Clinical Pathology 1974; 61: 577-8.
7. Palm R., Hallmans G. Zinc and copper metabolism in phenytoin therapy. Epilepsia 1982; 23: 453 -61.
8. Taylor JD, Lrahn PM, Higgins TN Serum copper levels and diphenylhydantoin. Letter to the editor. American Journal of Pathology 1974; 61: 577 - 8.
9. Palm R., Hanstom L., Hallmans G., Winblad B. The effects of phenytoin on serum and organ concentration of zinc and copper in cat. Epilepsia 1985; 26: 184 -8.
10. Kuzuya T., Hasegawa T., Shimizu K., Nabeshima T. Effect of anti-epileptic drugs on serum zinc and copper concentrations in epileptic patients. International Journal of Clinic Pharmacology, Therapy and Toxicolgoy 1993; 31: 61 -5.
11. Tutor JC, Fernandez MP, Paz JM Serum copper concentration and hepatic enzyme induction during long-term therapy with anti-convulsants. Clinical Chemistry 1982; 28: 1367-70.
12. Wong SH, Night JA, Hopfer SM Lipid peroxidation in plasma as measured by liquid-chromatographic separation of malondialdehyde- thiobarbituric acid adduct. Clinical Chemistry 1987; 33: 214 - 20.
13. Bergeron C. et al. Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motorneurons. Brain Research 1994; 659: 272 -6.
14. Haan JB, Newman JD, Kola I. CuZn-superoxide dismutase mRNA and enzyme activity, and susceptibility to lipid peroxidation, increases with aging in murine brains. Molecular Brain Research 1992; 13: 179-87.
15. Marttila RJ, Lorentz H., Rinne UK Oxygen toxicity protecting enzymes in Parkinson disease. Journal of Neurological Science 1988; 86: 321 - 31.
16. Hajimohammadreza I., Brammer M. Brain membrane fluidity and lipid peroxidation in the Alzheimer disease. Neuroscience Letter 1990; 112: 333-7.
17. Brooksbank Bwl, Martinez M. Lipid abnormality in the brain in adult Down syndrome and Alzheimer disease. Molecular Chemistry and Neuropathology 1989; 11: 157 -85.
18. Ceballos-Picot I. et al. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Downs syndrome. Brain Research 1991; 552: 198 -214.
19. Matkovicx B., Laszlo A., Szabo L. A comparative study of superoxide dismutase, catalase and lipid peroxidation in red blood cells from muscular dystrophy patients and normal controls. Clinica Chimica Acta 1982; 118: 289 -92.
20. Gonzales R. et al. Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant disease. Cancer Research 1984; 44: 4137 -9.
21. Nicotera TM et al. Elevated superoxide dismutase in Bloom syndrome: A genetic condition of oxidative stress. Cancer Research 1989; 49: 5239-43.
22. Kamal A. et al. Blood superoxide dismutase and plasma malondialdehyde among workers exposed to asbestos. American Journal of Industrial Medicine 1992; 21: 353-61.
23. Percival SS, Harris ED Regulation of Cu, Zn superoxide dismutase with copper. Biochemical Journal 1991; 274: 153-8.
24. Carri MT, Galiazzo F., Ciriolo MR, Rotilio G. Evidence for co-regulation of Cu, Zu superoxide dismutase and metallothionein gene expression in yeast through transcriptional control by copper via the ACE 1 factor. FEBS Letters 1991; 278: 263-6.
25. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radical Biology & Medicine 1995; 18: 321- 36.
26. Meister A., Anderson ME Glutathione. Annual Reviews of Biochemistry 1983; 52: 711 - 60.
27. Miranda AF, Wiley MJ, Wells PG Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetricnoic acid and buthionine sulfoximine in murine embryo culture. Toxicology and Applied Pharmacology 1994; 124: 230-41.
28. Wong M., Helston LM, Wells PG Enhancement of murine phenytoin teratogenicity by gammaglutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl mallet. Teratology 1989; 40: 127-41.